{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:20:17Z","timestamp":1787170817540,"version":"build-2736575974"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>POEMS syndrome is a rare hematologic disorder related to plasma cell dyscrasia. The Castleman disease variant of POEMS syndrome is extremely rare and often misdiagnosed. In this study, we aim to present a noteworthy case of POEMS syndrome mainly manifested as multiple pleural effusion and renal impairment without M protein.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 47-year-old woman was admitted to the hospital with a 7-month history of lower extremity edema and 3 months of abdominal distension. Computed tomography revealed poly-serosal effusion and hepatosplenomegaly, while ultrasound showed multiple superficial lymphadenopathies. Serum protein electrophoresis and bone biopsy indicated no evidence of monoclonal plasma cell proliferation. Pathological results obtained from lymph node biopsy revealed Castleman disease (CD). The patient was ultimately diagnosed with the Castleman disease variant of POEMS syndrome without M protein. Renal function gradually declined in the later stages of the disease. After transferring to another hospital, the patient received a VPD chemotherapy regimen (Pomalidomide, Bortezomib, and Dexamethasone) and hemodialysis. Effusions in multiple serosal cavities were reduced, and renal function improved significantly following active treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>POEMS syndrome without M protein is often misdiagnosed as other conditions. In patients presenting with multiple systemic manifestations, the possibility of POEMS syndrome or CD should be considered.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2025.1537944","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T02:17:22Z","timestamp":1750040242000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["A case report of Castleman disease variant of POEMS syndrome presenting with prominent polyserositis and renal impairment"],"prefix":"10.3389","volume":"12","author":[{"given":"Congcong","family":"Min","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ailing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushuang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueli","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/jnnp-2011-301706","article-title":"Different neurological and physiological profiles in POEMS syndrome and chronic inflammatory demyelinating polyneuropathy.","volume":"83","author":"Nasu","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B2","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1002\/ajh.26240","article-title":"POEMS syndrome: 2021 Update on diagnosis, risk-stratification, and management.","volume":"96","author":"Dispenzieri","year":"2021","journal-title":"Am J Hematol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1182\/blood.2019000931","article-title":"Overview of Castleman disease.","volume":"135","author":"Dispenzieri","year":"2020","journal-title":"Blood."},{"key":"B4","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/s41572-021-00317-7","article-title":"Castleman disease.","volume":"7","author":"Carbone","year":"2021","journal-title":"Nat Rev Dis Primers."},{"key":"B5","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/bjh.12236","article-title":"New advances in the diagnosis and treatment of POEMS syndrome.","volume":"161","author":"Li","year":"2013","journal-title":"Br J Haematol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1002\/ajh.27081","article-title":"POEMS syndrome: Update on diagnosis, risk-stratification, and management.","volume":"98","author":"Dispenzieri","year":"2023","journal-title":"Am J Hematol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1136\/bmj.2.4996.802","article-title":"Peripheral neuritis in myelomatosis.","volume":"2","author":"Crow","year":"1956","journal-title":"Br Med J."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1182\/blood-2002-07-2299","article-title":"POEMS syndrome: definitions and long-term outcome.","volume":"101","author":"Dispenzieri","year":"2003","journal-title":"Blood."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1136\/jnnp-2012-304874","article-title":"Ambiguous effects of anti-VEGF monoclonal antibody (bevacizumab) for POEMS syndrome.","volume":"84","author":"Sekiguchi","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e2022007","DOI":"10.4084\/MJHID.2022.007","article-title":"VEGF and IL-6 Correlation in POEMS: a Potential Upcoming Marker of Active Disease and Early Autologous BMT Response.","volume":"14","author":"Tomasso","year":"2022","journal-title":"Mediterr J Hematol Infect Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1182\/blood-2016-10-746933","article-title":"International, evidence-based consensus diagnostic criteria for HHV-8-negative\/idiopathic multicentric Castleman disease.","volume":"129","author":"Fajgenbaum","year":"2017","journal-title":"Blood."},{"key":"B12","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/cas.13439","article-title":"Clinical characteristics and outcomes of Castleman disease: A multicenter study of 185 Chinese patients.","volume":"109","author":"Zhang","year":"2018","journal-title":"Cancer Sci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e163","DOI":"10.1016\/S2352-3026(16)00006-5","article-title":"Idiopathic multicentric Castleman\u2019s disease: a systematic literature review.","volume":"3","author":"Liu","year":"2016","journal-title":"Lancet Haematol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/ajh.21707","article-title":"Serum immunoglobulin free light chain measurements and heavy chain isotype usage provide insight into disease biology in patients with POEMS syndrome.","volume":"85","author":"Stankowski-Drengler","year":"2010","journal-title":"Am J Hematol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1093\/ndt\/gfv261","article-title":"Renal impairment in patients with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes syndrome: incidence, treatment and outcome.","volume":"31","author":"Ye","year":"2016","journal-title":"Nephrol Dial Transplant."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e5047","DOI":"10.1097\/MD.0000000000005047","article-title":"Case report and literature review: Glomerular and neurologic thrombotic microangiopathy as a primary manifestation of multicentric castleman disease.","volume":"95","author":"Flahault","year":"2016","journal-title":"Medicine (Baltimore)."},{"key":"B17","doi-asserted-by":"publisher","first-page":"iii119","DOI":"10.1093\/ndt\/gfr245","article-title":"Renal involvement in a large cohort of Chinese patients with Castleman disease.","volume":"27","author":"Xu","year":"2012","journal-title":"Nephrol Dial Transplant."},{"key":"B18","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/ndt\/gfq427","article-title":"Renal involvement in Castleman disease.","volume":"26","author":"El Karoui","year":"2011","journal-title":"Nephrol Dial Transplant."},{"key":"B19","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41408-021-00540-1","article-title":"Treatment and outcomes of POEMS syndrome: changes in the past 20 years.","volume":"11","author":"Yu","year":"2021","journal-title":"Blood Cancer J."},{"key":"B20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.5045\/br.2022.2022001","article-title":"Update on the POEMS syndrome.","volume":"57","author":"Kim","year":"2022","journal-title":"Blood Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/s41375-019-0391-2","article-title":"What is the best first-line treatment for POEMS syndrome: autologous transplantation, melphalan and dexamethasone, or lenalidomide and dexamethasone?","volume":"33","author":"Zhao","year":"2019","journal-title":"Leukemia."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1182\/blood-2018-07-862334","article-title":"International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease.","volume":"132","author":"van Rhee","year":"2018","journal-title":"Blood."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1182\/blood-2018-11-884577","article-title":"Phase 2 study using oral thalidomide-cyclophosphamide-prednisone for idiopathic multicentric Castleman disease.","volume":"133","author":"Zhang","year":"2019","journal-title":"Blood."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1007\/s00277-018-3347-0","article-title":"Effectiveness of rituximab-containing treatment regimens in idiopathic multicentric Castleman disease.","volume":"97","author":"Dong","year":"2018","journal-title":"Ann Hematol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/leu.2016.168","article-title":"Prognostic study for overall survival in patients with newly diagnosed POEMS syndrome.","volume":"31","author":"Wang","year":"2017","journal-title":"Leukemia."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1093\/brain\/awh519","article-title":"Polyneuropathy in POEMS syndrome: role of angiogenic factors in the pathogenesis.","volume":"128","author":"Scarlato","year":"2005","journal-title":"Brain."},{"key":"B27","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s00277-010-1149-0","article-title":"Clinical characteristics and long-term outcome of patients with POEMS syndrome in China.","volume":"90","author":"Li","year":"2011","journal-title":"Ann Hematol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1537944\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T02:17:23Z","timestamp":1750040243000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1537944\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,16]]},"references-count":27,"alternative-id":["10.3389\/fmed.2025.1537944"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1537944","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,16]]},"article-number":"1537944"}}